Eyes On Glaucoma 2025 highlights advancements in disease care
Events

Eyes On Glaucoma 2025 highlights advancements in disease care

Largest virtual glaucoma meeting of the year sees record attendance.
FDA agrees to Atsena's regulatory pathway for XLRS gene therapy
Pipeline

FDA agrees to Atsena's regulatory pathway for XLRS gene therapy

Expansion of LIGHTHOUSE study will support potential BLA submission in early 2028 to become the first FDA-approved treatment for the inherited retinal disease.
 4DMT cuts 25% of workforce and fast-tracks wet AMD gene therapy program
Business

4DMT cuts 25% of workforce and fast-tracks wet AMD gene therapy program

Company reports streamlined planning to advance phase 3 clinical trials of 4D-150, under evaluation to deliver a single, low-dose, and sustained multi-year intravitreal injection.
LENZ and Théa partner on Canadian commercialization of presbyopia eye drop
Pipeline

LENZ and Théa partner on Canadian commercialization of presbyopia eye drop

Licensing and commercialization agreement gives LENZ $70 million in upfront and milestone payments; news comes as company awaits FDA approval.
Alcon to purchase LumiThera
Business

Alcon to purchase LumiThera

Targeting a Q3 sale, acquisition includes Valeda Light Delivery System, the first and only PBM treatment for early-to-intermediate dry AMD.
Eyenovia rebrands as Hyperion DeFi, Inc with new focus
Business

Eyenovia rebrands as Hyperion DeFi, Inc with new focus

Name change aligns with company's pivot toward decentralized finance and focus on a cryptocurrency treasury reserve strategy; plans remain to commercialize Optejet.
Vision Expo shifting to single annual event in 2026
Events

Vision Expo shifting to single annual event in 2026

Starting next February in Orlando, the trade-only conference and exhibition will rotate its location throughout major U.S. cities moving forward.
Surprising protective role of estrogen may lower glaucoma risk in women
Research

Surprising protective role of estrogen may lower glaucoma risk in women

Age at menopause had a significant effect on RNFL thickness among women.
Happy 4th of July!
Events

Happy 4th of July!

A word from the
Diabetic patients may have worsening visual outcomes after orbital cellulitis
Research

Diabetic patients may have worsening visual outcomes after orbital cellulitis

Study highlights susceptibility of diabetic patients to poor vision following orbital cellulitis.
AOA inducts new leadership during 2025 Optometry's Meeting
Business

AOA inducts new leadership during 2025 Optometry's Meeting

Vowing pushback against vision plan abuses, Jacquie M. Bowen, OD, is named president as the 2025-2026 AOA Board of Trustees are inducted.
Regener-Eyes ends recall of remaining older product inventory
Products

Regener-Eyes ends recall of remaining older product inventory

Company previously issued voluntary recall for older bottles in December 2024 following the launch of updated bottles with backflow prevention technology.
New data finds increased prevalence of refractive surgery among cataract patients
Research

New data finds increased prevalence of refractive surgery among cataract patients

Clinicians may need to consider new ways of calculating IOL power due to prevalence of high myopia and previous refractive surgery.
Bausch + Lomb unveils 2025 state of dry eye survey results
Research

Bausch + Lomb unveils 2025 state of dry eye survey results

Building on 2024 findings, latest results indicate a need for more patient education to dispel ongoing misconceptions surrounding dry eye.
Opus Genetics' VEGA-3 presbyopia trial meets endpoints for phentolamine 0.75%
Pipeline

Opus Genetics' VEGA-3 presbyopia trial meets endpoints for phentolamine 0.75%

Topline data found a statistically significant number of patients achieved a ≥15-letter improvement in binocular DCNVA; H2 2025 NDA submission expected.
AOA report analyzes ocular risks of GLP-1RAs
Research

AOA report analyzes ocular risks of GLP-1RAs

Released during the 2025 Optometry’s Meeting, this comprehensive rundown dives into potential rare ophthalmic side effects associated with use—and offers clinical care recommendations.
ForSight Robotics raises $125M to advance robotic ophthalmic surgical platform
Business

ForSight Robotics raises $125M to advance robotic ophthalmic surgical platform

Financing to support expansion of ORYOM, the world’s first hybrid intraocular ophthalmic platform designed to deliver advanced capabilities beyond standard cataract surgery.
Earlier diabetes diagnosis may lead to worsening DR progression
Research

Earlier diabetes diagnosis may lead to worsening DR progression

Study identifies mechanisms for the potential protective effect of later diabetes diagnosis on DR severity.
Alcon offers first look at TRYPTYR, debuts new innovations for contact lens ordering app
Events

Alcon offers first look at TRYPTYR, debuts new innovations for contact lens ordering app

Company announces partnership with Revolution EHR to advance its MARLO platform; highlights new dry eye and contact lens offerings.
Stuart Therapeutics reports initial phase 3 DED eye drop data
Pipeline

Stuart Therapeutics reports initial phase 3 DED eye drop data

Results on ST-100 (vezocolmitide), a collagen mimetic peptide, support its role as a fast-acting resolution for dry eye signs and symptoms.